Latest advice for medicines users
Welcome to the latest issue of
Drug Safety Update
April 2013 (Volume 6, Issue 9)
Drug Safety Update is essential reading for all healthcare professionals, bringing you the very latest information and advice to support the safer use of medicines.
Drug safety advice
Insulin degludec (Tresiba▼) is available in prefilled pen devices (known as FlexTouch) in two strengths: 100 units/mL; and 200 units/mL. The 100 units/mL strength is also available in cartridge form (called Penfill).
Cilostazol (Pletal) is restricted to second-line use in patients for whom life-style modifications and other appropriate interventions have failed to sufficiently improve their symptoms. .
We would like to remind healthcare professionals to remain vigilant with regard to drug names because serious errors have occurred when medicines with similar names have been confused
A review of available safety data for strontium ranelate (Protelos) has raised concern about its cardiovascular safety beyond the already recognised risk of venous thromboembolism. An analysis of randomised controlled trial data has identified an increased risk of serious cardiac disorders, including myocardial infarction